ALEMBIC PHARMA has announced its results for the quarter ended June 2019. Here is a detailed performance review of the same:
No. of Mths Qtr. Ending | 3 Jun-18* | 3 Mar-19* | 3 Jun-19* | QoQ Change | YoY Change | |
---|---|---|---|---|---|---|
Net Sales | Rs m | 8,625 | 9,270 | 9,489 | 2.4% | 10.0% |
Other income | Rs m | 1 | 34 | 33 | -2.4% | 3190.0% |
Turnover | Rs m | 8,626 | 9,303 | 9,522 | 2.4% | 10.4% |
Expenses | Rs m | 7,115 | 7,489 | 7,240 | -3.3% | 1.8% |
Gross profit | Rs m | 1,510 | 1,783 | 1,964 | 10.1% | 30.0% |
Depreciation | Rs m | 276 | 300 | 354 | 18.2% | 28.3% |
Interest | Rs m | 16 | 51 | 50 | -2.0% | 217.2% |
Profit before tax | Rs m | 1,220 | 1,467 | 1,593 | 8.6% | 30.6% |
Tax | Rs m | 315 | 149 | 360 | 141.3% | 14.0% |
Profit after tax | Rs m | 904 | 1,318 | 1,233 | -6.4% | 36.4% |
Gross profit margin | % | 17.5 | 19.2 | 20.7 | ||
Effective tax rate | % | 25.9 | 10.2 | 22.6 | ||
Net profit margin | % | 10.5 | 14.2 | 13.0 |
To see how ALEMBIC PHARMA has performed over the last eight quarters,please visit here.
Over the last one year,ALEMBIC PHARMA share price has moved down from Rs 589.3 to Rs 518.0, registering a Loss of Rs 71.3 or around 12.1%.
Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 12,504.9 (down 0.2%). Over the last one year it has moved down from 15,302.1 to 12,504.9, a gain of 2,797 points (down 18.3%).
Overall, the S&P BSE SENSEX is down 2.5% over the year.
At the current price of Rs 518.0, the price to earnings (P/E) ratio of ALEMBIC PHARMA stands at 15.6 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.6 times.
For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.
For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.
Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.
A look at what India's top equity mutual funds bought and sold in January 2021.
Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
More
| |
Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 36.4%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!